Respiratory Pathogen (Pneumonia) Panel with Antibiotic Resistance Genes, Molecular
Lower Respiratory Pathogen Detection Panel by Molecular Method is a multiplex assay designed to detect most common bacterial and viral pathogens causing pneumonia. Testing is performed on sputum or bronchoalveolar lavage (BAL) specimens. Depending on the actual panel employed the most common organisms detected by this assay include Adenovirus, Coronavirus, Human Metapneumovirus, Influenza A, Influenza B, Parainfluenza Virus, Human Rhinovirus/Enterovirus, Respiratory Syncytial Virus, Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae, and gram positive and negative bacteria typically found in pneumonia.
Respiratory pathogens cause acute local and systemic disease of varying severity, with the most severe cases occurring in children, the elderly and immunocompromised individuals. Symptoms can include: nasal discharge, congestion, fever, wheezing, coughing, shortness of breath, headache and myalgia. Due to the similarity of diseases caused by many viruses and bacteria, diagnosis based on clinical symptoms alone is difficult. Therefore, identification of potential causative agents will aid the physician in determining appropriate patient treatment and public health response for disease containment.
Traditionally, culture has been the primary method for detecting respiratory pathogens. However, the relatively long time required to grow and identify bacteria and the difficulty or inability to grow some viruses and other pathogens has been a problem with traditional culture. Using molecular methods to detect specific pathogen DNA or RNA simultaneously reduces the time required for diagnosis but also allows detection of organisms not amenable to culture.
Diagnostic testing for antibiotic resistance has historically been culture-based, where susceptibility is performed in conjunction with identification. The main disadvantage of culture based antibiotic resistance which also is considered as phenotyping, is the time to perform the testing. Depending on the microorganism, it might take 3-4 days to get results out; usually it takes couple days to grow bacteria and then to perform susceptibility testing. Another disadvantage of culture-based methods is multiple organisms or co-growth, where specimen contains more than one microbe. This might become difficult to pinpoint what is causing the infection and what may have been living on the plate. Obtaining a pure culture is critical to accuracy in identifying and looking for antibiotic resistance susceptibility.
Since accurate and timely detection of antibiotic-resistance patterns are crucial for the timing and right antibiotic selection for the treatment of infection, new techniques such as molecular have become more adaptive and better for antibiotic detection. Antibiotic resistance testing by molecular or polymerase chain reaction (PCR), which belongs to genotyping tests, is currently the best approach to screen for multi drug resistance organisms. The main advantage of molecular tests is that they identify specific resistance mechanisms within the same day. These tools allow clinicians to make better informed decisions more quickly—and deliver the most effective antibiotic to the patient.
Most panels will detect the common respiratory viral, bacterial and fungal pathogens associated with respiratory infection and antibiotic resistance genes associated with tested pathogens. Results from detected pathogens and antibiotic resistance genes will give suggestions on drug classes or drugs used for respiratory infection treatment.
As with all molecular tests, the respiratory pathogen panel by molecular will only detect pathogens and resistance genes it is designed to detect. It may therefore give false negative results with uncommon pathogens or may not detect organisms that possess unusual resistance mechanisms. For this reason, cultures are often initiated at the time of molecular testing to confirm and or clarify the panel results. Further, due to the sensitivity of molecular methods they may give false positive results due to small numbers of common bacteria or contaminants that are not actually causing clinical infection.
Tested pathogens by molecular method or panels varies from technology, vendor, laboratory and diagnostic purposes. Most common tested and detected pathogens from lower and upper respiratory tract pathogens are listed below. Some are very specific and some less specific.
Viral Pathogens
Adenoviruses
Adenoviruses are a double-stranded DNA non-enveloped DNA virus with seven species (A to G) categorized by hemagglutination and approximately 55 serotypes. Acute respiratory diseases are mostly caused by Adenovirus Species B, C, and E. Adenovirus infection in humans can cause many diseases, including cystitis, encephalitis, conjunctivitis (pink eye), diarrhea, pneumonia, myocarditis, and other respiratory diseases. Infections can involve all age ranges. These viruses usually cause mild and self-limiting infections in healthy adults. The infection is more concerning in immunocompromised individuals, pregnant women, or young children – especially malnourished children. Most children have had an adenovirus infection of some kind by the age of 10. Adenovirus infection has also been associated with military service and is commonly found in new recruits.
Coronaviruses
Coronaviruses constitute a group of RNA viruses which cause respiratory infections in a variety of animal species including humans. In humans, episodic outbreaks occur mostly during the winter and spring months. The pediatric population is particularly vulnerable, although the disease has been reported across all the age groups. There are five known types of coronaviruses that can infect people. There are two alpha types: 229E and NL63; two beta types: OC43, HKU1; and the type that causes SARS. These viruses are most commonly associated with upper respiratory tract infections; however, they have also been detected in individuals with lower respiratory tract infections.
SARS-CoV-2 (SARS COVID-19)
SARS-CoV-2 is the causative agent of coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared the 2019–20 coronavirus outbreaks a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and a pandemic on 11 March 2020. Symptoms of COVID-19 range from mild fever, cough, and shortness of breath, muscle pain, diarrhea, and sore throat to pneumonia and multi-organ failure. The disease is transmitted from human-to-human by close contact, via respiratory droplets generated by sneezing and coughing. It may also spread when one touches a contaminated surface and then their face. The incubation period appears to be 2-14 days. The laboratory testing for the COVID-19 and the associated SARS-CoV-2 virus includes methods that detect the presence of the viral nucleic acids, rapid tests to detect viral antigens and those that detect antibodies produced in response to infection. Detection of the viral RNA by molecular method such as reverse transcriptase polymerase chain reaction (RT-PCR) is preferable and widely adopted test in COVID-19 testing, especially for early detection and infection spreading management.
Human Metapneumoviruses
Human Metapneumoviruses are in the family Paramyxoviridae. Infection in infants and young children is commonly associated with bronchiolitis. The two genotypes, A and B, can circulate at the same time and do not appear to differ in the severity of illness.
Influenza A and B Virus
Influenza A and B are RNA viruses belonging to Orthomyxoviridae family. Both influenza A and B can cause disease with Influenza A infection been more severe. Influenza A can be subtyped by the hemagglutinin (H) and neuraminidase (N) genes; subtypes H1N1 and H3N2 are the strains that most commonly infect humans. Influenza is a highly contagious, acute, viral infection of the respiratory tract. It is a communicable disease that is easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the fall and winter months. Rapid diagnostics with increased sensitivity are essential for the reliable detection of influenza A and B, allowing immediate, effective treatment decisions.
Parainfluenza Viruses
Parainfluenza viruses are RNA viruses belonging to Paramyxoviridae family. Parainfluenza viruses are divided into four types antigenically and genetically having capability of causing respiratory infection. Children less than six months old are more susceptible to Parainfluenza Virus 3 infection, with outbreaks occurring in neonatal intensive care units and epidemics are most common in the spring and summer. Parainfluenza Virus 4 infection affects all age groups and a periodicity of infection has not been established.
Respiratory Syncytial Virus
Respiratory Syncytial Virus (RSV) is an RNA virus and is seen as a frequent pathogen in acute respiratory diseases. It can cause recurrent respiratory infections from infancy through adult life. Infection with this virus can cause serious complications in the elderly, children, and infants, especially those that are immunocompromised (impaired immunity) or have cardiopulmonary disease. In congenital heart disease, the infection can be lethal. RSV is the most common cause of respiratory diseases in hospitalized infants younger than one year of age. RSV may produce croup, bronchitis, bronchiolitis, or interstitial pneumonia. The infection is spread largely by particle droplets (as opposed to small particle aerosols).
Rhinoviruses and Enteroviruses
Rhinoviruses and Enteroviruses are related RNA viruses belonging to Picornavirus family. There are more than 100 serotypes of Human Rhinovirus based on the serology of the capsid protein. Rhinovirus is well known as causing the “common cold”, but may also be involved in other respiratory diseases such as asthma. Enteroviruses are divided into four species with total of 89 serotypes. Individual serotypes can be associated with different clinical manifestations, including nonspecific respiratory illnesses in infants or adults.
Bacterial Pathogens
Acinetobacter baumannii and other species
Although, Acinetobacter baumannii is an uncommon member of the normal skin flora, it is counted for cause of hospital-acquired pneumonia in critically ill and immunocompromised patients.
Chlamydia pneumoniae
Chlamydia pneumoniae is a gram-negative obligate intracellular bacterium that causes acute respiratory infections and is a common cause of community-acquired pneumonia. Outbreaks occur in schools, military barracks, and nursing homes. No peak season has been identified for C. pneumoniae infections.
Enterobacter cloacae complex
Enterobacter cloacae and associated species are gram-negative rod-shaped bacteria belonging to the Enterobacteriaceae family been part of the normal gut flora. Their pathogenicity has been implicated in numerous nosocomial infections, which are notable for their severity in ICU patients. Up to 31% of nosocomial Enterobacter pneumonia cases in the ICU are associated with strains demonstrating cephalosporin resistance
Escherichia coli
E. coli is an enteric gram-negative bacterium of the normal intestinal flora. Although, not typical for pneumonia, E. coli is found in approximately 5-10% of community-acquired and hospital-acquired pneumonia.
Haemophilus influenzae
Haemophilus influenzae is a gram-negative coccobacillus present in normal flora of the oropharynx. When introduced in lower respiratory airways, H. Influenzae becomes a pathogen and can cause disease such as pneumonia. There are two groups of H. influenzae strains; classified based on the polysaccharide capsule presented. Those with the capsule or encapsulated strains are further divided into six serotypes (a through f). H. influenzae infection is caused by nontypeable strains and predominantly affects children under the age of one and the elderly 12, with a mortality rate of 13-20%. Approximately 20-35% of isolated strains are resistant to amoxicillin.
Klebsiella oxytoca
Klebsiella oxytoca is an aerobic gram-negative, rod-shaped bacterium mostly found in mucosal surfaces of nasopharynx and gastrointestinal tract. K. oxytoca is an opportunistic infections agent mainly causing hospital acquired pneumonia; however, it is known of causing soft tissue infections, urinary tract infections and septicemia. This pathogen has developed resistance to several antibiotics including extended-spectrum β-lactams.
Klebsiella pneumoniae
Klebsiella pneumoniae is a gram-negative bacterium rod-shaped, mainly found as part of the normal flora of the human mouth and skin. Infection by K. pneumoniae is caused when introduced in lower respiratory tract. K. pneumoniae can cause alveolar damage leading to lower respiratory disease and pneumonia. K. pneumoniae is associated most often with nosocomial infections in the elderly or immunocompromised. Klebsiella spp. are opportunistic pathogens accounting for 7-14% of hospital-acquired pneumonia and ~8% of all nosocomial bacterial infections in the United States.
Pseudomonas aeruginosa
P. aeruginosa is a gram-negative opportunistic pathogen capable of causing systematic diseases including respiratory. It is count as a leading cause of nosocomial infections. It has been shown to cause more than 10% of all hospital acquired infections. In addition, this opportunistic pathogen has been reported as the causative agent in both communities acquired and hospital-acquired pneumoniae. P. aeruginosa has become resistant to several antibiotics and multi-drug resistant P. aeruginosa infection is becoming an increasing problem in hospitals.
Chlamydia pneumoniae
C. pneumoniae is an obligate, intracellular, Gram-negative bacterium known as a major cause of bacterial pneumonia. Chlamydia pneumoniae infection is generally a mild illness that most commonly causes an upper respiratory tract infection such as a sore throat, ear or sinus infection. C. pneumoniae can also cause lower respiratory infections like bronchitis and lung infections like pneumonia. C. pneumonia can be effectively treated using appropriate antimicrobial therapy; therefore, correct and rapid laboratory diagnosis is very crucial in-patient management.
Legionella pneumophila and Legionella species
Legionella pneumophila is a gram-negative bacillus that causes Pontiac fever, a flu-like illness. In addition, it can cause a pneumonia that may progress to a severe multisystem illness (Legionnaire disease). There are at least six serogroups of L. pneumophila and at least 22 species of Legionella. L. pneumophilia is hard to grow on routine bacteriologic culture media and it stains weakly. The best way to test for L. pneumophilia is by by molecular method.
Mycoplasma pneumoniae
M. pneumoniae is an important cause of pneumonia and contributes up to 20% of all community-acquired pneumonias across a wide range of age groups. Individuals acquire M. pneumoniae through aerosol inhalation. After an incubation period of 2-3 weeks, the individuals develop symptoms of upper respiratory tract infection and tracheobronchitis. In healthy individual, the disease tends to be mild and requires supportive care and antibiotics in an ambulatory setting; however, in individuals with compromised immune status and/or other co-morbidities, the infections result in hospitalization, severe morbidity and death.
Serratia marcescens
Serratia are gram-negative bacteria that are common nosocomial pathogens and colonizers. S. marcescens is the primary pathogenic species of the Serratia genus. It is of particular concern due to its emerging antibiotic resistance to commonly used agents like β-lactams, aminoglycosides, carbapenems, and fluoroquinolones.
Staphylococcus aureus
S. aureus is a gram-positive bacterium considered as most common, opportunistic bacterium, capable of causing infection in almost all organs and tissue with wide range of diseases. It is among the most common etiologic agents in lower respiratory tract infections comprising 3-14% of all cases of community-acquired pneumonia and is, at 17%, the most frequently reported isolate in hospital-acquired pneumonia. It is estimated that approximately 40% of S. aureus isolates may be methicillin resistant.
Streptococcus agalactiae (GBS)
S. agalactiae are gram-positive bacteria mainly causing infection and disease in infants. S. agalactiae can cause both early onset neonatal disease, characterized by sepsis and pneumonia within the first seven days of life; and late onset disease with meningitis and sepsis between day seven and three months of age. In adult patients, the spectrum of S. agalactiae infections includes bacteremia, pneumonia, meningitis, and endocarditis.
Streptococcus pneumoniae
S. pneumoniae is a gram-positive bacterium that colonizes the upper respiratory tract and is the most frequently isolated respiratory pathogen in community-acquired pneumonia. S. pneumoniae is the main cause of community acquired pneumonia and meningitis in children and the elderly and of sepsis in immunocompromised patients. The organism also causes many types of pneumococcal infections other than pneumonia such as bronchitis, rhinitis, acute sinusitis, otitis media, conjunctivitis, meningitis, sepsis, osteomyelitis, septic arthritis, endocarditis, peritonitis, pericarditis, cellulitis, and brain abscess.
Streptococcus pyogenes
S. pyogenes or Group A Streptococcus (GAS) is a beta-hemolytic bacterium classified Lancefield serogroup A. GAS is the major cause of bacterial acute pharyngitis accounting for 15-30% of the acute pharyngitis cases in children and 5-20% of the cases in adults. Acute pharyngitis caused by GAS, if left undiagnosed and untreated, can lead to severe complications including acute rheumatic fever, scarlet fever, glomerulonephritis, and streptococcus toxic shock syndrome. Therefore, identification of GAS infection on time is important as it allows the disease to be treated effectively with antibiotics and prevent any further complications.
- Diagnosis of lower respiratory tract infection
- Diagnosis of pneumonia and pneumonia like syndromes
- Therapy monitoring and disease management
Detection of any above listed pathogens in the appropriate clinical setting suggest an infection or possible co-infection with detected organism(s).
Not Detected (Negative)
Bronchoalveolar lavage (BAL) or bronchial washings, expectorated sputum and endotracheal aspirate collected in sterile container.
Nasopharyngeal swab (collected in appropriate transport medium) can be also used in some cases.
Stability (Sputum and BAL)
- Ambient: 1-4 hours
- Refrigerated: 1-3 days
- Frozen: One month
Stability (Nasopharyngeal swab)
- Ambient: 1-3 days
- Refrigerated: 3-5 days
- Frozen: One month
- Clin Microbiol Infect. 2018 Oct;24(10):1055-1063. [PMID: 29208560]
- Expert Rev Mol Diagn. 2013 Nov;13(8):779-88. [PMID: 24151847]
- Future Microbiol. 2018 Dec;13:1697-1708. [PMID: 30547684]
- Clin Infect Dis. 2016 Apr 1;62(7):817-823. [PMID: 26747825]
- Clin Infect Dis. 2011 May;52 Suppl 4:S296-304. [PMID: 21460288]
- Adv Exp Med Biol. 2015;835:9-13. [PMID: 25252894]
- Respiration. 2016;92(5):286-294. [PMID: 27649510]
- Future Microbiol. 2010 Jun;5(6):901-16. [PMID: 20521935]
- Clin Microbiol Rev. 2008 Oct;21(4):716-47. [PMID: 18854489]